Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$700.03 - $830.35 $14,000 - $16,607
20 Added 666.67%
23 $16,000
Q1 2023

May 15, 2023

SELL
$680.49 - $826.97 $1.47 Million - $1.79 Million
-2,160 Reduced 99.86%
3 $2,000
Q4 2022

Feb 08, 2023

BUY
$705.89 - $766.39 $1.53 Million - $1.66 Million
2,163 New
2,163 $1.56 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $72.4B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Okabena Investment Services Inc Portfolio

Follow Okabena Investment Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Okabena Investment Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Okabena Investment Services Inc with notifications on news.